Cadrenal Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cadrenal Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2022 to Q3 2024.
  • Cadrenal Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $2.2K, a 91.8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.2K -$24.7K -91.8% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $8.66K -$24K -73.5% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $14.9K -$23.3K -60.9% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $21K -$22.6K -51.8% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $26.9K Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $32.6K Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $38.2K Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $43.6K Dec 31, 2022 10-K 2024-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.